Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Thoracic Malignancies
Would you give RT to a young BAP1+ patient with lung cancer s/p NAC and P/D who has biopsy-proven pleural recurrence after adjuvant chemo?
Related Questions
How does a history of radiation pneumonitis impact your decision on future lung SBRT?
How would you approach a localized but unresectable adenoid cystic carcinoma of the distal trachea?
When contouring locally advanced NSCLC, how do you define your ITV if your iGTV overlaps with an OAR?
How do you define treatment volumes for patients treated with neoadjuvant chemoimmunotherapy for resectable NSCLC who are no longer surgical candidates or decline surgery?
Would you offer any degree of hypofractionation with concurrent chemotherapy for NSCLC?
How would you manage out-of-field nodal recurrence of NSCLC post definitive CRT and adjuvant immunotherapy?
When would you include treatment of the entire staple line for an NSCLC staple line recurrence?
Would you ever consider repeating chemoradiation for patients with locally recurrent small cell lung cancer after prior chemoradiation for LS-SCLC?
In a patient with node-positive limited-stage small cell lung cancer, how do you approach radiation in a patient whose small primary tumor resolves after one cycle of chemotherapy?
How would you approach a patient with limited stage SCLC who progressed immediately after completing chemoradiation with brain metastasis?
